People · Operator
Named in public records as an officer, director or promoter · active 2010–2014 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Emerald Therapeutics, Inc. | — | Other Health Care | Series A | $15.1M | $113.2M | 2010 |
Daniel J. Kleinbaum at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel J. Kleinbaum on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Max R Levchin | 1 | 2 |
| Luke R. Nosek | 1 | 2 |
| Brian R. Singerman | 1 | 1 |
| Brian J. Frezza | 1 | 1 |
| Brian Frezza | 1 | 1 |
| Luke J. Nosek | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.